Wednesday, April 26, 2017 12:18:00 AM
She said this: "The approval process could take as little as 90 days, after which we will be prepared to take orders for shipment through our recently announced distribution agreement,” concluded Griffin. The Company plans to reach commercialization for Lodonal in Kenya in 2017."
It COULD take only 90 days, but often things don't go as quickly as desired. 90 days would be GREAT! They could then begin taking orders, but actual sales would probably take a bit longer as would actual payment. Still, this is great news! They say the hope to reach commercialization in Kenya sometime yet in 2017 so it kind of gives me the impression it won't be quite as soon as we would like to think.
What I liked about this announcement is that this ND is for both cancer AND HIV!
Here is what it said:
Hopefully we will hear from Nigeria in the near future.
If I'm not mistaken, the Nigeria NDA is just for HIV. Is that right? Can anyone confirm that?
Things are really looking up here!
FEATURED Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • May 15, 2024 10:30 AM
Swifty Global Announces Impressive Financial Results for Q1 2024 • DRCR • May 15, 2024 10:25 AM
Branded Legacy Inc. Invites Shareholders to Celebrate Milestones at Open House: Announces Share Buyback and Commitment to Authorized Share Count • BLEG • May 15, 2024 8:30 AM
Alliance Creative Group (ACGX) Releases Q1 2024 Financial and Disclosure Report with an 88% increase in Net Income from Q1 2023 to Q1 2024 • ACGX • May 15, 2024 8:30 AM
Category V Biotech, Inc. Announces Letter of Intent to Acquire Genetic Networks, Expanding into Biotechnology Sector • CATV • May 15, 2024 8:00 AM
POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • POET • May 14, 2024 10:09 AM